- Home
- BNR vs VRAR Comparison
BNR vs VRAR Comparison
Compare BNR & VRAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- VRAR
- Stock Information
- Founded
- BNR 2014
- VRAR 2016
- Country
- BNR China
- VRAR United States
- Employees
- BNR 674
- VRAR N/A
- Industry
- BNR Medical Specialities
- VRAR Retail: Computer Software & Peripheral Equipment
- Sector
- BNR Health Care
- VRAR Technology
- Exchange
- BNR Nasdaq
- VRAR Nasdaq
- Market Cap
- BNR 38.3M
- VRAR 33.3M
- IPO Year
- BNR 2020
- VRAR 2021
- Fundamental
- Price
- BNR $4.22
- VRAR $1.49
- Analyst Decision
- BNR
- VRAR Strong Buy
- Analyst Count
- BNR 0
- VRAR 1
- Target Price
- BNR N/A
- VRAR $2.62
- AVG Volume (30 Days)
- BNR 29.7K
- VRAR 135.2K
- Earning Date
- BNR 08-21-2025
- VRAR 05-15-2025
- Dividend Yield
- BNR N/A
- VRAR N/A
- EPS Growth
- BNR N/A
- VRAR N/A
- EPS
- BNR N/A
- VRAR N/A
- Revenue
- BNR $72,112,038.00
- VRAR $8,756,789.00
- Revenue This Year
- BNR $136.32
- VRAR $23.96
- Revenue Next Year
- BNR N/A
- VRAR $12.15
- P/E Ratio
- BNR N/A
- VRAR N/A
- Revenue Growth
- BNR 0.53
- VRAR N/A
- 52 Week Low
- BNR $2.18
- VRAR $0.50
- 52 Week High
- BNR $7.90
- VRAR $7.00
- Technical
- Relative Strength Index (RSI)
- BNR 63.77
- VRAR 52.95
- Support Level
- BNR $3.06
- VRAR $1.31
- Resistance Level
- BNR $3.50
- VRAR $1.38
- Average True Range (ATR)
- BNR 0.21
- VRAR 0.11
- MACD
- BNR 0.05
- VRAR 0.01
- Stochastic Oscillator
- BNR 95.65
- VRAR 66.67
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About VRAR The Glimpse Group Inc.
The Glimpse Group Inc is a diversified Virtual and Augmented Reality platform company, comprised of multiple VR and AR software and services companies, and designed with the specific purpose of cultivating companies in the emerging VR/AR industry.